Home Featured San Diego Life Science VC Drops 34% to $1.4B, Its Lowest Since 2022, as Bay Area Funding Holds
FeaturedFinanceIndustry NewsLeasingLife ScienceSan Diego

San Diego Life Science VC Drops 34% to $1.4B, Its Lowest Since 2022, as Bay Area Funding Holds

Share
vials inside a lab
Photo by Testalize.me on Unsplash
Share

San Diego life science companies raised just $1.4 billion through the third quarter, their weakest nine months since 2022, as Savills' Q3 2026 data show vacancy rising to 28.5 percent while the Bay Area holds steady and Seattle slides.

Thank you for your interest in The Registry. If you'd like to read further, you must Subscribe or Log In below to read the rest of this content.

Share

Featured Content


Recent Posts